This document discusses complications of acute pancreatitis, with a focus on pseudocyst and pancreatic necrosis. It summarizes that pseudocysts are fluid collections contained by a well-defined capsule that can develop after acute or chronic pancreatitis. Complications include infection, rupture, enlargement, and erosion into blood vessels. Diagnosis involves imaging and labs. Treatment depends on symptoms and includes drainage or resection. Pancreatic necrosis involves death of pancreatic tissue and can become infected. Interventions like drainage may be needed if necrosis is infected or causing other issues. Both conditions are serious complications of acute pancreatitis.
Revised Atlanta classification of Acute PancreatitisDr M Venkatesh
The most important change in Atlanta classification is the categorization of the various pancreatic collections.
In acute IEP, collections that do not have an enhancing capsule are called APFCs; after development of a capsule, they are referred to as
pseudocysts
In necrotizing pancreatitis,a collection without an enhancing capsule is called an ANC (usually in the first 4 weeks) and thereafter a WON, which has an enhancing capsule.
The most important distinction between collections in necrotizing pancreatitis and those associated with acute IEP is the presence of nonliquefied material in collections due to necrotizing pancreatitis.
Intestinal fistulas pose the greatest challenge to the General Surgeon. The presentation provides abrief guideline for management of this complex problem.
Revised Atlanta classification of Acute PancreatitisDr M Venkatesh
The most important change in Atlanta classification is the categorization of the various pancreatic collections.
In acute IEP, collections that do not have an enhancing capsule are called APFCs; after development of a capsule, they are referred to as
pseudocysts
In necrotizing pancreatitis,a collection without an enhancing capsule is called an ANC (usually in the first 4 weeks) and thereafter a WON, which has an enhancing capsule.
The most important distinction between collections in necrotizing pancreatitis and those associated with acute IEP is the presence of nonliquefied material in collections due to necrotizing pancreatitis.
Intestinal fistulas pose the greatest challenge to the General Surgeon. The presentation provides abrief guideline for management of this complex problem.
Pancreatitis -a detailed study ( medical information )martinshaji
Pancreatitis is the Inflammation of the pancreatic parenchyma. Acute condition of diffuse pancreatic inflammation & auto digestion, presents with abdominal pain, and is usually associated with raised pancreatic enzyme levels in the blood &urine. this is a detailed study pancreatitis describing factors such as definition , epidemiology , etiology , pathophysiology , treatment , prevention , imaging techniques , diagnosis , lab investigations , images , drugs , control etc
please comment
thank u
15 cm in length, 60-140 gm, consists of head, body & tail; pancreatic duct empty into duodenum or common bile duct
Histologically, consists of 2 components:
1) Exocrine: 80-85%, consists of numerous glands (acini) lined by columnar basophilic cells containing zymogen granules, which form lobules; ductal system
Trypsin, chemotrypsin, aminopeptidase, amylase, lipase
2) Endocrine: islets of Langerhans, which are invaded by capillaries. Islets consist of:
4 main cell types: B (insulin), A (glucagon), D (somatostatin), PP cells (pancreatic polypeptide)
2 minor cell types: D1 (VIP) & enterochromaffin cells (serotonin
2 cases of colorectal trauma - one due to blunt trauma abdomen and one due to penetrating trauma to rectum are discussed in the light of colorectal trauma
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
COMPLICATIONS OF ACUTE PANCREATITIS
1.
2. THINKING OF COMPLICATIONS ?
Can we think of life without complications in today’s
life?
So let us see how Acute Pancreatitis can make the
whole thing complicated
3. COMPLICATIONS OF ACUTE
PANCREATITIS:
WITH SPECIAL EMPHASIS ON
PSEUDOCYST AND ACUTE
PANCREATIC NECROSIS
PREPARED BY: DR. DIPANJAN MANDAL
MALDA MEDICAL COLLEGE & HOSPITAL
5. ACUTE FLUID COLLECTIONS
30-50% cases
Content: inflammatory exudates and/or enzyme-rich
pancreatic secretions
Routes of extension:
Diagnosis: CECT/MRI/EUS
Management: wait & watch
• Into lesser sac
• Behind the pancreatic head
• Behind the lt & rt colons on the
psoas muscle
• Into the small bowel mesentry
& buldging through the
transverse mesocolon
6. POSTNECROTIC PANCREATIC &PERIPANCREATIC
FLUID COLLECTION
Contain both solid & fluid components
Arise from liquefaction of solid necrosis and/or
pancreatic duct disruption
Mature lesion has a wall without an epithelial lining
around the collection- “walled off necrosis” (WON)
Diagnosis:
Management: same as that for pancreatic necrosis
CECT, MRI, EUS
CECT- Extraluminal gas
Image guided FNA for Gram’s
stain
& culture [Definitive diagnosis]
8. PANCREATIC PSEUDOCYST
A fluid collection contained within a well-defined capsule.
Present for > 4 weeks after disease onset
Doesn’t possess an epithelial lining
May develop in the context of
Acute pancreatitis(10-15% of cases),
Chronic pancreatitis(20-40% of cases) or
trauma
9. Location:
• Lesser sac in proximity to the pancreas
• Large pseudocysts can extend into the
Paracolic gutters,
Pelvis,
Scrotum,
Mediastinum or
Thorax
10. Composition:
• Thick fibrous capsule – not a true epithelial lining
• Pseudocyst fluid: similar electrolyte conc. to that of plasma
high conc. of amylase, lipase & enterokinases such as
trypsin
• Relatively clear watery fluid
• Hemorrhage- may contain clot-become xanthochromic
• Infection-pus
11. PATHOGENESIS & CLASSIFICATION
Pancreatic ductal disruption sec. to
1. Acute pancreatitis- Necrosis
2. Chronic pancreatitis- Elevated pancreatic duct
pressures from strictures or ductal calculi
3. Trauma
12. PATHOGENESIS
Acute pancreatitis: Pancreatic necrosis
Ductular disruption
Leakage of enzyme-rich
secretion from inflammed
area of gland
Accumulation in space
adjacent to pancreas
Inflammatory response
induces formation of
distinct cyst wall composed
of granulation tissue,
organizes with connective
tissue & fibrosis
13. THE D’EDIGO CLASSIFICATION
CONTEXT PANCREATIC
DUCT
DUCT-
PSEUDOCYST
COMMUNICATI
ON
Type I Acute
postnecrotic
pancreatitis
Normal No
Type II Acute-on-chronic
pancreatitis
Abnormal (no
stricture)
50:50
Type III Chronic
pancreatitis
Abnormal
(stricture)
Yes
14. PRESENTATION
o Symptoms
1. Persistent abdominal
pain >3 weeks(80-
90%)
2. Nausea/vomiting
3. Early satiety
4. Bloating, indigestion
5. Anorexia, weight loss
6. Abdominal mass
Signs
1. Tenderness
2. Abdominal fullness
15. COMPLICATIONS (~ 10% CASES)
Process 0utcomes
1.Infection(25% cases) Abscess
Systemic sepsis
2.Rupture
Into the gut Gastrointestinal bleeding
Internal fistula
Into the peritoneum Peritonitis
3. Enlargement
pressure effects Obstructive jaundice from biliary
compression
Bowel obstruction
pain
4. Erosion into a vessel Hemorrhage into the cyst
Haemoperitoneum
16. DIAGNOSIS
Suspect a pseudocyst
Acute pancreatitis fails to recover after a week of
Rx
After initial improvement, symptoms return
Amylase levels persistently high
Persistent abdominal pain
Epigastric mass palpated after pancreatitis
17. DIAGNOSIS
Clinical features: epigastric discomfort or
pain,anorexia, early satiety, nausea, mild fever, back
pain & a palpable mass.
Labs: persistently elevated serum amylase (>5000U/mL)
Plain X-ray: not very useful
Ultrasound: 75-90% sensitive
Advantage:
1) better able to determine the
extent of solid tissue within a fluid
collection
2) often used to guide FNA
Disadvantage: limited by
operator skill, patient’s
habitus, overlying bowel
gas
18. CECT:
• Most accurate (sensitivity 90-100%)
• Advantages are many
Triphasic helical CT: delineate the regional
arteries & veins
MRI: outlines the solid component of the lesions
ERCP: both diagnostic & therapeutic role
MRCP: noninvasive
similar diagnostic accuracy to ERCP.
19. MANAGEMENT
Two principal indications for treating pseudocysts
General features of a pseudocyst imp in considering the
most appropriate Rx
Thickness of the pseudocyst wall
Location
Contents
Number
Etiology
Main pancreatic duct anatomy & degree of disruption
To relieve symptoms
To treat complications
22. DRAINAGE V/S RESECTION
Drainage procedures are preferred
• Preserve pancreatic function
• Technically easier
• Lower mortality rate
• Complications & mortality rates of int drainage is ½
of ext drainage
23. CYSTOGASTROSTOMY
Ideal when pseudocyst adherent to post stomach &
indenting it
Disadvantage: not a dependent stoma, may act as
sump when pseudocyst is large can accumulate
gastric debris
24.
25.
26.
27. PANCREATIC NECROSIS
Approx 20% of pts with acute pancreatitis
25-70% develop infected necrosis
Risk higher when involvement is more extensive(>30% of
the gland) & with time( 24% by end of 1st wk; 36% by end
of 2nd wk;71% beyond of 3rd wk)
Clinical features: same as that of acute pancreatitis
30. FATE
<1cm : resolve spontaneously.
2-4 cm :demarcated by macrophages that slowly
phagocytose the necrotic material; inner content of
foci become liquified
>5cm :macrophages rich in hemosiderin+ other
immune cells form a thin layer of granulation tissue
by 10-20 days of disease onset, after 20-30 days
become a fibrous capsule increasing in thickness .
Necrotic areas slowly resolved& replaced by fibrotic
scar tissue (necrosis-fibrosis sequence)
31. MICROBIOLOGY
Routes of entry
1. Hematogenous
2. Transpapillary reflux of duodenal content into pancreatic
duct
3. Translocation of intestinal bacteria & toxins via
mesenteric lymphatics to systemic circulation via
thoracic duct
4. Reflux of bacteriobilia via a distrupted pancreatic duct
into necrotic parenchyma
5. Transperitoneal spread
33. DIAGNOSIS
Ranson, Glascow, APACHE ,BISAP used for severity
stratification
CECT:
a. Gold standard
b. Disadvantage: contrast used might worsen necrosis
and/or exacerbate existing renal failure
c. Useful to grade the severity by CTSI
MRI
EEU
Prognostic markers:
a) CRP: 85% accurate; requires 3-4 days to reach a
diagnostic level; threshold value>120 mg/dl
35. Image guided( CT or ultrasound) FNA : Indications
a. >30% necrosis+ persistent symptoms
b. Smaller areas of necrosis+ clinical suspicion of
infected necrosis
36. INDICATIONS OF INTERVENTIONS
1) Infected necrosis, confirmed by culture +ve FNA
2) Persistent sepsis from infected necrosis
3) Failure of attempted radiological drainage
4) Massive hemorrhage or bowel perforation
5) Pts with sterile necrosis, those clinically
deteriorating & who have a clear target lesion.
37. EARLY SURGERY V/S LATE INTERVENTION
Early surgery : more difficult & dangerous —significant
risk of bleeding
There may be infection of sterile necrosis
Current concept: intervention
should be as late as possible after
disease onset( preferably >4 wks)
because necrosis has stopped
extending, clear demarcation b/w
viable & non-viable tissues, infected
necrotic tissues have become
organized & “walled-off”
39. Factors to determine the type of intervention:
1. Anatomical location
2. Infection status
3. Complexity of target lesion(s)
4. Physiological status
5. Comorbidity of an individual patient
6. Availbility of expertise with the type of intervention
40. PRINCIPLES FOR INTERVENTION
Removal of all infected & necrotic tissue and fluid
Preservation of vital tissues
Avoidance of intraoperative hemorrhage
41. OPEN AND MINIMALLY INVASIVE APPROACHES TO THE
TREATMENT OF PANCREATIC NECROSIS
Editor's Notes
Tell about one to two sentences about each complications – don’t go into details